Markers of cerebrovascular injury, inflammation, and plasma lipids are associated with Alzheimer’s disease cerebrospinal fluid biomarkers in cognitively normal persons
Manuscript Number:
21-5400R1
Author(s):
Michelle A. Erickson, Jeffrey J. Iliff, Deidre Jansson, Ge Li, Elaine R. Peskind, Ron Thomas, Marie Wang
Disclosures
Michelle A. Erickson
Nothing to Disclose
Jeffrey J. Iliff
Nothing to Disclose
Deidre Jansson
Nothing to Disclose
Ge Li
Nothing to Disclose
Elaine R. Peskind
Consulting Fees:
Chair, DSMB, Eli Lilly Phase III Study of Donanemab anti-amyloid monoclonal antibody
Acadia - Scientific Advisory Board for pimavanserin for dementia related psychosis
Avanir - Scientific Advisory Board for l-dextromethorphan + quinidine clinical trial in traumatic brain injury
Equity:
Approximately $1500 of Bristol Myers Squibb stock
Lecture Fees:
Acadia - dementia related psychosis - approximately $5,000 in 2019
Patents/Royalties
Expert witness for cases involving undue influence and testamentary capacity - unrelated to this manuscript.